7 hours ago
8
LAS VEGAS, April 26, 2025 (GLOBE NEWSWIRE) -- Abstracts presented at this year's American Urological Association (AUA) Annual Meeting in Las Vegas will spotlight a series of innovative research studies poised to transform prostate cancer care.
Featured abstracts include advancements in artificial intelligence that surpass radiologist performance in cancer detection, validation of a non-invasive urine test eliminating the need for digital rectal exams, new findings on the impact of testosterone replacement therapy after prostate surgery and an analysis of online misinformation about prostate cancer. Together, these studies underscore the rapid progress and multidisciplinary efforts shaping the future of urological oncology.
Researchers will present their study findings covering important updates on prostate cancer from April 26 to 29. Adam Weiner, MD, a urologic oncologist at Cedars Sinai Hospital, posed in-depth questions to the abstract authors, providing key insights into their research.
"The diagnosis and management of prostate cancer has evolved tremendously in recent years,” said Dr. Weiner. "Today, patients with prostate cancer can live longer with fewer effects on their quality of life. Still, researchers are constantly striving to reduce harm caused by treatments and procedures without compromising cancer care. In these works, the study authors have attacked this issue from many approaches. We owe a debt of gratitude to the efforts of these researchers who work to make the lives of our patients better.”
The following abstracts are spotlighted in the AUA Press Program:
Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
- The Impact of Testosterone Replacement Therapy vs. No Treatment: Delaying Biochemical Recurrence Post-RP
- Digital Rectal Exam No More: Validated Accuracy of MYPROSTATESCORE 2.0 (MPS2) Using First-Catch, Non-DRE Urine
- Online Misinformation About Prostate Cancer
- Multimodal MRI-TRUS AI Model Exceeds Radiologist Performance in Prostate Cancer Detection
A recording of the key findings from the abstract authors is available to all press registrants. Fill out the registration form on the website to be added to the virtual programming: https://www.auanet.org/AUA2025/register/press-registration
NOTE TO REPORTERS: Presenting authors and moderators are available to discuss their findings. To arrange an interview with an expert, please contact the AUA Communications Team at [email protected].
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 26,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
CONTACT: Corey Del Bianco
American Urological Association
443-689-4033
